Blueprint Medicines Corporation (BPMC)
USD 78.44
(-3.97%)
USD 78.44
(-3.97%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 722.86 Million USD | -1.73% |
| 2022 | 723.74 Million USD | -10.0% |
| 2021 | 804.12 Million USD | 65.94% |
| 2020 | 484.6 Million USD | 13.27% |
| 2019 | 427.83 Million USD | 46.75% |
| 2018 | 291.54 Million USD | 68.84% |
| 2017 | 172.67 Million USD | 72.07% |
| 2016 | 100.34 Million USD | 59.17% |
| 2015 | 63.04 Million USD | 58.67% |
| 2014 | 39.73 Million USD | 89.21% |
| 2013 | 21 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 175.22 Million USD | 3.08% |
| 2024 Q2 | 169.99 Million USD | 1.83% |
| 2024 Q1 | 166.93 Million USD | -4.76% |
| 2023 Q3 | 180.99 Million USD | -1.22% |
| 2023 Q4 | 175.27 Million USD | -3.16% |
| 2023 FY | 711.19 Million USD | -1.73% |
| 2023 Q1 | 184.31 Million USD | 0.32% |
| 2023 Q2 | 183.22 Million USD | -0.59% |
| 2022 Q2 | 189.29 Million USD | 15.81% |
| 2022 Q1 | 163.45 Million USD | -60.67% |
| 2022 FY | 723.74 Million USD | -10.0% |
| 2022 Q4 | 183.73 Million USD | -1.88% |
| 2022 Q3 | 187.25 Million USD | -1.08% |
| 2021 Q2 | 129.31 Million USD | 6.25% |
| 2021 Q4 | 415.6 Million USD | 202.27% |
| 2021 FY | 804.12 Million USD | 65.94% |
| 2021 Q1 | 121.71 Million USD | 1.47% |
| 2021 Q3 | 137.49 Million USD | 6.33% |
| 2020 Q4 | 119.94 Million USD | 7.47% |
| 2020 FY | 484.6 Million USD | 13.27% |
| 2020 Q1 | 119.8 Million USD | -0.92% |
| 2020 Q2 | 133.25 Million USD | 11.23% |
| 2020 Q3 | 111.6 Million USD | -16.25% |
| 2019 FY | 427.83 Million USD | 46.75% |
| 2019 Q1 | 90.8 Million USD | 7.87% |
| 2019 Q2 | 109.02 Million USD | 20.07% |
| 2019 Q3 | 107.1 Million USD | -1.76% |
| 2019 Q4 | 120.91 Million USD | 12.9% |
| 2018 Q2 | 70.9 Million USD | 18.44% |
| 2018 FY | 291.54 Million USD | 68.84% |
| 2018 Q4 | 84.17 Million USD | 9.88% |
| 2018 Q3 | 76.6 Million USD | 8.03% |
| 2018 Q1 | 59.86 Million USD | 15.75% |
| 2017 Q1 | 34.17 Million USD | 17.57% |
| 2017 FY | 172.67 Million USD | 72.07% |
| 2017 Q4 | 51.72 Million USD | 10.8% |
| 2017 Q3 | 46.67 Million USD | 16.39% |
| 2017 Q2 | 40.1 Million USD | 17.37% |
| 2016 Q1 | 22.28 Million USD | 11.09% |
| 2016 Q4 | 29.06 Million USD | 26.13% |
| 2016 Q3 | 23.04 Million USD | -11.24% |
| 2016 Q2 | 25.96 Million USD | 16.52% |
| 2016 FY | 100.34 Million USD | 59.17% |
| 2015 Q4 | 20.05 Million USD | 26.11% |
| 2015 FY | 63.04 Million USD | 58.67% |
| 2015 Q3 | 15.9 Million USD | 5.44% |
| 2015 Q2 | 15.08 Million USD | 25.67% |
| 2015 Q1 | 12 Million USD | -16.03% |
| 2014 Q1 | 6.95 Million USD | 0.0% |
| 2014 Q2 | 8.19 Million USD | 17.92% |
| 2014 Q3 | 10.28 Million USD | 25.49% |
| 2014 Q4 | 14.29 Million USD | 38.93% |
| 2014 FY | 39.73 Million USD | 89.21% |
| 2013 FY | 21 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AbCellera Biologics Inc. | 275.23 Million USD | -162.637% |
| Alkermes plc | 996.24 Million USD | 27.442% |
| Agenus Inc. | 78.18 Million USD | -824.576% |
| Aptorum Group Limited | 10.56 Thousand USD | -6841287.469% |
| Ardelyx, Inc. | 169.93 Million USD | -325.37% |
| Dyadic International, Inc. | 9.15 Million USD | -7797.793% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -3148.375% |
| Lantern Pharma Inc. | 17.87 Million USD | -3943.396% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -10637.775% |
| Novavax, Inc. | 779.12 Million USD | 7.221% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -791.738% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -779.436% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -3622.535% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -2341.603% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -1260.644% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -89.979% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -2873.928% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -1808.846% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -2249.163% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -753.276% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -4040.809% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -329.161% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -2109.571% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -352.39% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | 59.842% |
| AlloVir, Inc. | 180.93 Million USD | -299.519% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -62.172% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -2335.351% |
| Bicycle Therapeutics plc | 216.92 Million USD | -233.235% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -320.508% |
| ChromaDex Corporation | 56.37 Million USD | -1182.146% |
| Chimerix, Inc. | 93.38 Million USD | -674.032% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -5096.834% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -380.191% |
| CRISPR Therapeutics AG | 463.49 Million USD | -55.959% |
| Precision BioSciences, Inc. | 92.46 Million USD | -681.784% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -184.542% |
| Fortress Biotech, Inc. | 200.19 Million USD | -261.078% |
| Fortress Biotech, Inc. | 200.19 Million USD | -261.078% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -2107.479% |
| ImmuCell Corporation | 9.61 Million USD | -7416.209% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -358.046% |
| Immix Biopharma, Inc. | 16.14 Million USD | -4378.384% |
| Incyte Corporation | 1.19 Billion USD | 39.281% |
| Innoviva, Inc. | 132.15 Million USD | -446.984% |
| IO Biotech, Inc. | 91.44 Million USD | -690.504% |
| Jaguar Health, Inc. | 42.01 Million USD | -1620.483% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -327.028% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -757.252% |
| ContextLogic Inc. | 387 Million USD | -86.786% |
| MiMedx Group, Inc. | 229.72 Million USD | -214.661% |
| MEI Pharma, Inc. | 34.78 Million USD | -1978.083% |
| NextCure, Inc. | 67.63 Million USD | -968.736% |
| Onconetix, Inc. | 34.9 Million USD | -1970.794% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -5571.277% |
| Opthea Limited | 191.96 Million USD | -276.554% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -26170.713% |
| Vaxcyte, Inc. | 468.04 Million USD | -54.444% |
| PDS Biotechnology Corporation | 43.04 Million USD | -1579.306% |
| Precigen, Inc. | 84.18 Million USD | -758.699% |
| Pharming Group N.V. | 225.49 Million USD | -220.572% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -330.718% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -896.143% |
| PureTech Health plc | 144.59 Million USD | -399.914% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -454.924% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -194.855% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -2873.928% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -216.102% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -2242.464% |
| Acelyrin, Inc. | 422.06 Million USD | -71.268% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -5606081.17% |
| Summit Therapeutics Inc. | 87.68 Million USD | -724.374% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -1850.305% |
| Senti Biosciences, Inc. | 94.7 Million USD | -663.276% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -485.061% |
| Elevation Oncology, Inc. | 45.44 Million USD | -1490.628% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -2352.954% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -18237.194% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -446.897% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -2020.76% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -8453.556% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -298.708% |
| Seer, Inc. | 110.49 Million USD | -554.232% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -923.969% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -673.295% |
| ESSA Pharma Inc. | 32.13 Million USD | -2149.513% |
| GlycoMimetics, Inc. | 39.28 Million USD | -1740.03% |
| GT Biopharma, Inc. | 13.57 Million USD | -5224.551% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -228.827% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -259.427% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -178.64% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -1173.562% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -1236.651% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -7173.967% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | -79.12% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -3718.802% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | -1325.958% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -178.389% |
| Aptose Biosciences Inc. | 52.35 Million USD | -1280.665% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -4916.254% |
| Soligenix, Inc. | 7.79 Million USD | -9173.095% |
| Century Therapeutics, Inc. | 56.07 Million USD | -1189.189% |
| Kura Oncology, Inc. | 165.8 Million USD | -335.973% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -531.281% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -8589.278% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -29028.37% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -571.193% |
| Autolus Therapeutics plc | 196.72 Million USD | -267.446% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -753.87% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -520.732% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -3629.356% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -124.66% |
| GRI Bio, Inc. | 11.33 Million USD | -6280.062% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -10145.063% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -450.991% |
| IGM Biosciences, Inc. | 265.59 Million USD | -172.171% |
| INmune Bio, Inc. | 29.89 Million USD | -2317.919% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -318.919% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -1693.063% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -4423.717% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -4492.056% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -1064.065% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -572.291% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -162.198% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -139.794% |
| Verastem, Inc. | 92.08 Million USD | -685.002% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -3929.55% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -289.21% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -495.403% |
| Histogen Inc. | 14.27 Million USD | -4964.889% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -4404.328% |
| Surrozen, Inc. | 18.55 Million USD | -3796.825% |
| Organovo Holdings, Inc. | 14.91 Million USD | -4746.537% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -14100.933% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -1111.367% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -2718.501% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -1437.806% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -9370.403% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -305.792% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -1392.036% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -195.04% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -4604.113% |
| Apollomics, Inc. | 54.14 Million USD | -1235.17% |
| Amarin Corporation plc | 272.35 Million USD | -165.409% |
| Mesoblast Limited | 5.9 Million USD | -12147.73% |
| Turnstone Biologics Corp. | 78.33 Million USD | -822.746% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -196.106% |
| Synaptogenix, Inc. | 8.31 Million USD | -8594.656% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -4855.855% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -185.653% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -2068.795% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -8085.276% |
| Exelixis, Inc. | 1.58 Billion USD | 54.445% |
| Better Therapeutics, Inc. | 38.26 Million USD | -1789.24% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -211.511% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | 15.475% |
| NLS Pharmaceutics AG | 11.8 Million USD | -6022.276% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -8888.678% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -2310.099% |
| Gritstone bio, Inc. | 148.37 Million USD | -387.188% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -949.739% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -4318.407% |
| Avid Bioservices, Inc. | 25.99 Million USD | -2680.662% |
| Insmed Incorporated | 949.26 Million USD | 23.85% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -4507.207% |
| MediWound Ltd. | 18.86 Million USD | -3731.148% |
| OmniAb, Inc. | 83.89 Million USD | -761.626% |
| Alector, Inc. | 248.8 Million USD | -190.537% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -208.509% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -1283.44% |
| Zai Lab Limited | 547.47 Million USD | -32.035% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -81.325% |
| Aura Biosciences, Inc. | 84.99 Million USD | -750.515% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -192.493% |
| Immunic, Inc. | 99.22 Million USD | -628.522% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -354.595% |
| Veracyte, Inc. | 357.93 Million USD | -101.954% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 91.982% |
| FibroGen, Inc. | 398.11 Million USD | -81.572% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -4986.988% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -10394.578% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -10044.375% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | 77.797% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -2693.882% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -128.361% |
| TG Therapeutics, Inc. | 198.47 Million USD | -264.208% |
| Galecto, Inc. | 35.62 Million USD | -1928.97% |
| Calithera Biosciences, Inc. | 40.68 Million USD | -1676.551% |
| Fortrea Holdings Inc. | 457.3 Million USD | -58.072% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -1231.775% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -2403.155% |
| XBiotech Inc. | 37.51 Million USD | -1827.115% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -949.739% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -3400.707% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -408.838% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -629.61% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -552.897% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | 24.564% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -2406.018% |
| Vaxxinity, Inc. | 56.05 Million USD | -1189.649% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -67.857% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -3140.321% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -552.007% |
| NexImmune, Inc. | 28.16 Million USD | -2466.294% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -12969.387% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -3940.02% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | 74.324% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -2739.314% |
| Scopus BioPharma Inc. | 11.71 Million USD | -6070.453% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -468.904% |
| Ainos, Inc. | 12.95 Million USD | -5480.791% |
| Pluri Inc. | 22.48 Million USD | -3115.574% |
| Prothena Corporation plc | 282.4 Million USD | -155.965% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -261.391% |
| Celularity Inc. | 215.05 Million USD | -236.124% |
| Rallybio Corporation | 78.93 Million USD | -815.802% |
| Cue Biopharma, Inc. | 19.54 Million USD | -3599.012% |
| MeiraGTx Holdings plc | 151.07 Million USD | -378.469% |
| Omeros Corporation | 94.75 Million USD | -662.906% |
| Humacyte, Inc. | 23.49 Million USD | -2976.397% |
| Immunocore Holdings plc | 308.04 Million USD | -134.665% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -21223.333% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -732.166% |
| CalciMedica, Inc. | 21.81 Million USD | -3213.292% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -868.204% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -350.268% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -321.998% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -145.087% |
| Pulmatrix, Inc. | 22.03 Million USD | -3180.066% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -1990.704% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -713.428% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -31.056% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -896.349% |
| Cytokinetics, Incorporated | 173.61 Million USD | -316.366% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -2000.18% |
| Nutriband Inc. | 5.73 Million USD | -12506.507% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -1557.444% |
| Vor Biopharma Inc. | 126.03 Million USD | -473.535% |
| Roivant Sciences Ltd. | 1.18 Billion USD | 39.213% |
| Evogene Ltd. | 27.79 Million USD | -2501.155% |
| ProKidney Corp. | 151.52 Million USD | -377.067% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -874.535% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -9297.273% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -17.686% |
| CorMedix Inc. | 48.95 Million USD | -1376.498% |
| BioLineRx Ltd. | 50.8 Million USD | -1322.899% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -379.669% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -1798.668% |
| Atai Life Sciences N.V. | 125.78 Million USD | -474.68% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -785.433% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -787.937% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -186.223% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -2107.883% |
| MediciNova, Inc. | 10.9 Million USD | -6531.591% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -461.14% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -9857.416% |
| GeoVax Labs, Inc. | 6.02 Million USD | -11903.325% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -51.747% |
| Biomea Fusion, Inc. | 126.13 Million USD | -473.085% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | 44.897% |
| Mereo BioPharma Group plc | 35.84 Million USD | -1916.799% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -278.285% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -214.35% |
| Absci Corporation | 73.66 Million USD | -881.268% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -2520.771% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -441.104% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -198.503% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -175.851% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -247.539% |
| Allakos Inc. | 196.05 Million USD | -268.701% |
| Imunon, Inc. | 20.31 Million USD | -3459.064% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -537.056% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -96.103% |
| BioAtla, Inc. | 129.68 Million USD | -457.389% |
| NLS Pharmaceutics AG | 11.8 Million USD | -6022.276% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -4462.652% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -751.246% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -1631.072% |
| XOMA Corporation | 46.46 Million USD | -1455.778% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -550.224% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -407.403% |
| aTyr Pharma, Inc. | 12.97 Million USD | -5469.466% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -597.365% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -318.153% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -183.737% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -1832.37% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -8688.782% |
| Akari Therapeutics, Plc | 16.8 Million USD | -4201.208% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -31688.502% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -141.503% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -10642.904% |
| UroGen Pharma Ltd. | 138.88 Million USD | -420.463% |
| Sutro Biopharma, Inc. | 243 Million USD | -197.463% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -9836.75% |
| Orgenesis Inc. | 45.75 Million USD | -1479.782% |
| Entera Bio Ltd. | 8.86 Million USD | -8058.702% |
| GH Research PLC | 41.22 Million USD | -1653.581% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -2711.813% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -770.361% |
| Xencor, Inc. | 306.97 Million USD | -135.477% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -14551.778% |
| Replimune Group, Inc. | 234.77 Million USD | -207.898% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -3427.891% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -276.891% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -10642.904% |
| Portage Biotech Inc. | 18.19 Million USD | -3871.982% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -9857.416% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -588.695% |
| OncoCyte Corporation | 25.63 Million USD | -2719.601% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -11758.721% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -6209.306% |
| Purple Biotech Ltd. | -22.46 Million USD | 3317.434% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -4286.292% |
| scPharmaceuticals Inc. | 65.17 Million USD | -1009.057% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -8451.799% |
| HilleVax, Inc. | 133.34 Million USD | -442.098% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -6928.303% |
| Tharimmune, Inc. | 9.45 Million USD | -7545.1% |
| Genprex, Inc. | 31.06 Million USD | -2227.263% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -285.472% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -2203.793% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -94391.634% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -13171.007% |
| OKYO Pharma Limited | 8243.57 USD | -8768685.854% |
| Savara Inc. | 15.74 Million USD | -4491.051% |
| Curis, Inc. | 58.35 Million USD | -1138.73% |
| Daré Bioscience, Inc. | 33.6 Million USD | -2050.77% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -14094.653% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -9588.527% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -2575.083% |
| BeiGene, Ltd. | 3.28 Billion USD | 78.006% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -3525.308% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -44.93% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -370.453% |
| Erasca, Inc. | 141.52 Million USD | -410.766% |
| bluebird bio, Inc. | 240.23 Million USD | -200.901% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -15867.863% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | 58.606% |
| DBV Technologies S.A. | 92.16 Million USD | -684.354% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -15867.863% |
| Moderna, Inc. | 6.39 Billion USD | 88.695% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -1596.498% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -4931.749% |
| Molecular Templates, Inc. | 63.09 Million USD | -1045.743% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -983.733% |
| Travere Therapeutics, Inc. | 472 Million USD | -53.148% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -404.4% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -1064.365% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -1565.041% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -247.312% |
| MacroGenics, Inc. | 217.21 Million USD | -232.786% |
| RenovoRx, Inc. | 11.39 Million USD | -6243.112% |
| Adicet Bio, Inc. | 152.03 Million USD | -375.448% |
| Prime Medicine, Inc. | 186.63 Million USD | -287.304% |
| Aditxt, Inc. | 25.95 Million USD | -2685.509% |
| Adagene Inc. | 41.83 Million USD | -1628.036% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -9788.527% |
| Quantum-Si incorporated | 111.65 Million USD | -547.383% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -320.635% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -4858.653% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -1917.925% |
| SciSparc Ltd. | 9.01 Million USD | -7921.984% |
| Vericel Corporation | 142.04 Million USD | -408.914% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -8250.341% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -3030.814% |
| Generation Bio Co. | 144.46 Million USD | -400.364% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -770.602% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -736.064% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -144.441% |
| Invivyd, Inc. | 205.75 Million USD | -251.321% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -901.761% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -7607.637% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -860.562% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -6926.937% |
| 2seventy bio, Inc. | 289.88 Million USD | -149.36% |
| ADMA Biologics, Inc. | 66.58 Million USD | -985.605% |
| Clene Inc. | 41.07 Million USD | -1659.942% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -5543.874% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -1219.186% |
| GeoVax Labs, Inc. | 6.02 Million USD | -11903.325% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -105.33% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -1867.932% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -2043.207% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -597.056% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -2118.113% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -324.518% |
| Vir Biotechnology, Inc. | 767.72 Million USD | 5.843% |
| Evaxion Biotech A/S | 22.27 Million USD | -3145.896% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -433.304% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -207.755% |
| Trevena, Inc. | 38.41 Million USD | -1781.813% |
| Surrozen, Inc. | 18.55 Million USD | -3796.825% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -804.198% |
| Cingulate Inc. | 22.75 Million USD | -3076.128% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 9748.438% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -1518.333% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -8679.04% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -604.831% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | 4.141% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -1064.515% |
| Clearmind Medicine Inc. | 8.74 Million USD | -8169.444% |
| Kronos Bio, Inc. | 128.11 Million USD | -464.215% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -759.812% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -24545.915% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -616.932% |
| Statera Biopharma, Inc. | 28.82 Million USD | -2407.365% |
| ImmunityBio, Inc. | 362.87 Million USD | -99.206% |
| Korro Bio, Inc. | 84.53 Million USD | -755.113% |
| Kineta, Inc. | 21.15 Million USD | -3316.813% |
| BioVie Inc. | 31.95 Million USD | -2162.461% |
| Codexis, Inc. | 66.51 Million USD | -986.715% |
| Celularity Inc. | 215.05 Million USD | -236.124% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -218.974% |
| Celcuity Inc. | 66.23 Million USD | -991.435% |
| Virax Biolabs Group Limited | 6.54 Million USD | -10940.997% |
| Cibus, Inc. | 320.3 Million USD | -125.679% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -1581.072% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -2035.862% |
| IN8bio, Inc. | 30.33 Million USD | -2282.77% |
| Kodiak Sciences Inc. | 277.32 Million USD | -160.659% |
| Annexon, Inc. | 143.72 Million USD | -402.954% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -466.545% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -3055.358% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -112847.031% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | 7.276% |
| Eyenovia, Inc. | 25.4 Million USD | -2745.187% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -415.17% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -12896.422% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -813.476% |
| Arcellx, Inc. | 200.19 Million USD | -261.071% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -1474.861% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -234.022% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -7159.827% |
| Moolec Science SA | 52.75 Million USD | -1270.337% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -1082.343% |
| Geron Corporation | 70.44 Million USD | -926.194% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -1453.204% |
| Royalty Pharma plc | 862.4 Million USD | 16.181% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -668.412% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -7649.479% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -3094.467% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -247.844% |
| Humacyte, Inc. | 23.49 Million USD | -2976.397% |
| Structure Therapeutics Inc. | 102.77 Million USD | -603.343% |
| 89bio, Inc. | 151.2 Million USD | -378.07% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -802.088% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -4871.534% |
| Genelux Corporation | 24.33 Million USD | -2870.458% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -2030.888% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -318.155% |
| Notable Labs, Ltd. | 14.77 Million USD | -4794.116% |
| Liquidia Corporation | 87.98 Million USD | -721.582% |
| Mustang Bio, Inc. | 48.5 Million USD | -1390.404% |
| Immunovant, Inc. | 282.7 Million USD | -155.691% |
| Quantum-Si incorporated | 111.65 Million USD | -547.383% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -3106.445% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -3298.98% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -608.604% |
| Acasti Pharma Inc. | 11.3 Million USD | -6296.434% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -3053.692% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -4423.717% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -1453.137% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -63611.77% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -4450.302% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -2379.202% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -1646.716% |
| PepGen Inc. | 84.76 Million USD | -752.772% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -2339.543% |
| United Therapeutics Corporation | 885.1 Million USD | 18.33% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -3057.012% |
| Solid Biosciences Inc. | 104.31 Million USD | -592.96% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -2108.859% |
| Immuneering Corporation | 58.41 Million USD | -1137.503% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -14100.933% |
| Silo Pharma, Inc. | 3.92 Million USD | -18331.605% |
| Belite Bio, Inc | 31.66 Million USD | -2182.623% |
| XOMA Corporation | 46.46 Million USD | -1455.778% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -970.113% |
| Bionomics Limited | 17.89 Billion USD | 95.96% |
| Apogee Therapeutics, Inc. | 93 Million USD | -677.245% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 2125.956% |
| uniQure N.V. | 285.08 Million USD | -153.559% |
| Cassava Sciences, Inc. | 105.95 Million USD | -582.221% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -9788.527% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -272.212% |
| Forte Biosciences, Inc. | 32.47 Million USD | -2125.763% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -8599.992% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -2359.129% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -12896.422% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -4986.988% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -8032.085% |
| Altimmune, Inc. | 30.55 Million USD | -2265.692% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -69.031% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 2125.956% |
| Compugen Ltd. | 43.97 Million USD | -1543.949% |
| Peak Bio, Inc. | 1249.13 USD | -57869056.933% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -875.258% |
| Benitec Biopharma Inc. | 22.38 Million USD | -3129.653% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -197.242% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -2432.533% |
| Zura Bio Limited | 62.63 Million USD | -1054.03% |
| PolyPid Ltd. | 21.04 Million USD | -3334.835% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -4341.269% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -2432.533% |
| Instil Bio, Inc. | 85.78 Million USD | -742.643% |
| argenx SE | 1.53 Billion USD | 52.863% |
| Immunome, Inc. | 122.82 Million USD | -488.553% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -1391.265% |
| Verona Pharma plc | 67.15 Million USD | -976.466% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -2692.586% |
| Shattuck Labs, Inc. | 93.61 Million USD | -672.172% |
| CervoMed Inc. | 14.95 Million USD | -4732.68% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -922.391% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -8360.452% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -1317.375% |
| Moolec Science SA | 52.75 Million USD | -1270.337% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -4294.709% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -445.329% |
| AnaptysBio, Inc. | 181.56 Million USD | -298.121% |
| Design Therapeutics, Inc. | 78.19 Million USD | -824.493% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -730.483% |
| NeurAxis, Inc. | 8.82 Million USD | -8094.589% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -5643.83% |
| Lumos Pharma, Inc. | 38.66 Million USD | -1769.549% |
| Achilles Therapeutics plc | 75.25 Million USD | -860.549% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -2692.586% |
| 180 Life Sciences Corp. | 13.47 Million USD | -5263.465% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -2627.526% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -24545.915% |
| Nutriband Inc. | 5.73 Million USD | -12506.507% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -552.519% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -1198.872% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -1320.745% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -993.604% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -1235.587% |
| Palisade Bio, Inc. | 13.32 Million USD | -5326.884% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -1491.889% |
| Beam Therapeutics Inc. | 554.19 Million USD | -30.435% |
| Neurogene Inc. | 55.58 Million USD | -1200.507% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -190.903% |
| AEON Biopharma, Inc. | 48.42 Million USD | -1392.62% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -647.452% |
| Sesen Bio, Inc. | 78.38 Million USD | -822.24% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -765.401% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -5642.965% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -60.282% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -722.461% |
| Athira Pharma, Inc. | 125.46 Million USD | -476.141% |
| Vaccinex, Inc. | 23.45 Million USD | -2981.906% |
| HCW Biologics Inc. | 21.02 Million USD | -3337.69% |
| XOMA Corporation | 46.46 Million USD | -1455.778% |
| Nektar Therapeutics | 190.9 Million USD | -278.654% |
| Arvinas, Inc. | 480 Million USD | -50.596% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -31688.502% |
| Merus N.V. | 200.49 Million USD | -260.54% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -599.396% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -1987.987% |
| Rezolute, Inc. | 70.38 Million USD | -926.981% |
| Clene Inc. | 41.07 Million USD | -1659.942% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -4313.482% |
| BeyondSpring Inc. | 24.86 Million USD | -2807.143% |
| Synlogic, Inc. | 58.53 Million USD | -1134.984% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -3940.135% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -15992.186% |
| Peak Bio, Inc. | 1249.13 USD | -57869056.933% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -1095.879% |
| Krystal Biotech, Inc. | 160.42 Million USD | -350.588% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -167.102% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -107.696% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -33416.465% |
| MannKind Corporation | 125.59 Million USD | -475.54% |
| Ikena Oncology, Inc. | 84.57 Million USD | -754.678% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -7393.117% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -706.756% |
| Gossamer Bio, Inc. | 183.75 Million USD | -293.374% |
| CohBar, Inc. | 12.38 Million USD | -5735.031% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -1325.087% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -2520.771% |
| Legend Biotech Corporation | 583.14 Million USD | -23.959% |
| Mural Oncology plc | 192.07 Million USD | -276.351% |
| Biora Therapeutics, Inc. | 67.14 Million USD | -976.535% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -4377.231% |
| Disc Medicine, Inc. | 91.12 Million USD | -693.263% |
| Champions Oncology, Inc. | 28.11 Million USD | -2471.544% |
| REGENXBIO Inc. | 321.15 Million USD | -125.08% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -13383.109% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -1196.472% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -1755.362% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -532.109% |
| Vaxart, Inc. | 90.72 Million USD | -696.752% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -8384.276% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -1589.161% |
| Cellectis S.A. | 97.32 Million USD | -642.767% |
| Longeveron Inc. | 21.25 Million USD | -3301.699% |
| Repare Therapeutics Inc. | 167.35 Million USD | -331.928% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | 46.88% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -855.597% |
| Revolution Medicines, Inc. | 498.76 Million USD | -44.93% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -10766.822% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -1544.585% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -869.112% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -938.071% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -6435.814% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 84.862% |
| Denali Therapeutics Inc. | 527.23 Million USD | -37.105% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -8250.341% |
| Veru Inc. | 101.34 Million USD | -613.245% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -2988.226% |
| Cingulate Inc. | 22.75 Million USD | -3076.128% |
| Passage Bio, Inc. | 108.38 Million USD | -566.914% |
| Context Therapeutics Inc. | 25.07 Million USD | -2783.07% |
| Exicure, Inc. | 14.07 Million USD | -5035.415% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -250.794% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -1569.386% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -7776.628% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -186.301% |
| Nuvalent, Inc. | 149.49 Million USD | -383.545% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -8860.825% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -597.406% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -3270.138% |
| OmniAb, Inc. | 83.89 Million USD | -761.626% |
| Anew Medical, Inc. | 1.3 Million USD | -55468.744% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -2106.266% |
| Lipocine Inc. | 15.08 Million USD | -4693.464% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -955.071% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -849.234% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -1693.063% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -529.434% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -3129.365% |
| Sage Therapeutics, Inc. | 664.14 Million USD | -8.841% |
| Ocugen, Inc. | 71.56 Million USD | -910.048% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -670.099% |
| Q32 Bio Inc. | 92.68 Million USD | -679.954% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -3313.909% |
| Alumis Inc. Common Stock | 158.17 Million USD | -357.004% |
| Equillium, Inc. | 50.6 Million USD | -1328.41% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -1058.32% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -5098.361% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -3731.735% |
| Galera Therapeutics, Inc. | 46.95 Million USD | -1439.607% |
| Evelo Biosciences, Inc. | 108.46 Million USD | -566.44% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -5732.945% |
| Dominari Holdings Inc. | 23.83 Million USD | -2932.771% |
| Edesa Biotech, Inc. | 9.22 Million USD | -7737.796% |
| vTv Therapeutics Inc. | 11.9 Million USD | -5970.891% |
| Bio-Techne Corporation | 563.03 Million USD | -28.386% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -76.823% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -168.966% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -446.475% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -4916.036% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -341.587% |
| Nkarta, Inc. | 131.65 Million USD | -449.078% |
| BioCardia, Inc. | 12.12 Million USD | -5863.708% |
| Iterum Therapeutics plc | 47.46 Million USD | -1422.839% |